Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 1
1966 2
1967 1
1970 1
1972 2
1973 1
1975 1
1976 2
1977 1
1979 3
1981 1
1983 1
1989 1
1990 1
1991 1
1993 1
1994 1
1995 2
1996 1
2001 2
2005 1
2006 1
2007 2
2008 2
2009 1
2011 3
2012 2
2013 1
2014 1
2016 2
2017 1
2018 2
2019 4
2020 4
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Results by year
Filters applied: . Clear all
Page 1
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer.
Clemons M, Ong M, Stober C, Ernst S, Booth C, Canil C, Mates M, Robinson A, Blanchette P, Joy AA, Hilton J, Aseyev O, Pond G, Jeong A, Hutton B, Mazzarello S, Vandermeer L, Kushnir I, Fergusson D; REaCT investigators. Clemons M, et al. Among authors: kushnir i. Eur J Cancer. 2021 Jan;142:132-140. doi: 10.1016/j.ejca.2020.08.019. Epub 2020 Oct 3. Eur J Cancer. 2021. PMID: 33023785 Free PMC article. Clinical Trial.
Chorangioma. A cytoskeletal profile.
Lifschitz-Mercer B, Fogel M, Kushnir I, Czernobilsky B. Lifschitz-Mercer B, et al. Among authors: kushnir i. Int J Gynecol Pathol. 1989;8(4):349-56. doi: 10.1097/00004347-198912000-00006. Int J Gynecol Pathol. 1989. PMID: 2478492
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.
Ritch E, Fu SYF, Herberts C, Wang G, Warner EW, Schönlau E, Taavitsainen S, Murtha AJ, Vandekerkhove G, Beja K, Loktionova Y, Khalaf D, Fazli L, Kushnir I, Ferrario C, Hotte S, Annala M, Chi KN, Wyatt AW. Ritch E, et al. Among authors: kushnir i. Clin Cancer Res. 2020 Mar 1;26(5):1114-1125. doi: 10.1158/1078-0432.CCR-19-1623. Epub 2019 Nov 19. Clin Cancer Res. 2020. PMID: 31744831 Free article.
Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.
Kushnir I, Kirk L, Mallick R, Kim RH, Graham GE, Breau RH, Lattouf JB, Violette PD, Pautler SE, Care M, Kapoor A, Jewett MAS, Wood L, Tanguay S, Heng DYC, Basappa NS, So A, Pouliot F, Reaume NM. Kushnir I, et al. Clin Oncol (R Coll Radiol). 2020 Jan;32(1):e10-e15. doi: 10.1016/j.clon.2019.07.010. Epub 2019 Aug 1. Clin Oncol (R Coll Radiol). 2020. PMID: 31378448
Active Surveillance in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System.
Kushnir I, Basappa NS, Ghosh S, Lalani AA, Hansen AR, Wood L, Kollmannsberger CK, Heng DYC, Bjarnason GA, Soulières D, Dawe DE, Tanguay S, Breau RH, Pouliot F, Kapoor A, Graham J, Reaume MN. Kushnir I, et al. Clin Genitourin Cancer. 2021 Dec;19(6):521-530. doi: 10.1016/j.clgc.2021.05.004. Epub 2021 May 15. Clin Genitourin Cancer. 2021. PMID: 34158246
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study.
Keizman D, Frenkel M, Peer A, Kushnir I, Rosenbaum E, Sarid D, Leibovitch I, Mano R, Yossepowitch O, Margel D, Wolf I, Geva R, Dresler H, Rouvinov K, Rapoport N, Eliaz I. Keizman D, et al. Among authors: kushnir i. Nutrients. 2021 Nov 28;13(12):4295. doi: 10.3390/nu13124295. Nutrients. 2021. PMID: 34959847 Free PMC article.
51 results